Equity · Healthcare
AXSM
Axsome Therapeutics, Inc. · NasdaqGM
The line runs $241 on 1 July through $194 on 28 September, on a scale from $180 to $260. Days the market did not trade hold the previous close, flat.
The chart above plots the price of AXSM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $241 on 1 July 2026 through $194 on 28 September 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 28, 2026
AXSM insider trades
AXSM has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 4 December 2025.
Showing the 12 most recent of 21 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 15 compensation filings in this window. The figures above count all of them.
AXSM reported financials
AXSM reported revenue of $638.5M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$183.2M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
AXSM earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
AXSM institutional holders
12 of the 45 institutional funds we track reported a AXSM position for the quarter ended 30 Jun 2026 — a combined $817.1M; the latest of those filings landed 02 Sep 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
AXSM fails-to-deliver
On 24 Aug 2026, 7 shares of AXSM failed to deliver (about $1K).
Source: SEC fails-to-deliver (CNS) data